Miao, Jin <br/><br/>
Prediction value of XRCC 1 gene polymorphism on the survival of ovarian cancer treated by adjuvant chemotherapy.  [electronic resource] 

 -  Asian Pacific journal of cancer prevention : APJCP  2012 
 - 5007-10 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2476-762X 
<br/><br/><label>Standard No.: </label>10.7314/apjcp.2012.13.10.5007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma, Clear Cell--drug therapy<br/>Adenocarcinoma, Mucinous--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bleomycin--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Cisplatin--administration & dosage<br/>Cystadenocarcinoma, Serous--drug therapy<br/>DNA-Binding Proteins--genetics<br/>Endometrial Neoplasms--drug therapy<br/>Female<br/>Follow-Up Studies<br/>Genetic Predisposition to Disease<br/>Humans<br/>Middle Aged<br/>Neoplasm Staging<br/>Ovarian Neoplasms--drug therapy<br/>Polymerase Chain Reaction<br/>Polymorphism, Genetic--genetics<br/>Prognosis<br/>Prospective Studies<br/>Survival Rate<br/>X-ray Repair Cross Complementing Protein 1